cilostazol has been researched along with Protein Aggregation, Pathological in 2 studies
Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, M | 1 |
| Saito, S | 1 |
| Inoue, T | 1 |
| Satoh-Asahara, N | 1 |
| Ihara, M | 1 |
| Shozawa, H | 1 |
| Oguchi, T | 1 |
| Tsuji, M | 1 |
| Yano, S | 1 |
| Kiuchi, Y | 1 |
| Ono, K | 1 |
1 review available for cilostazol and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Ac | 2020 |
1 other study available for cilostazol and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cilostazol; Humans; Peptide Fragments; Phosphodiesterase 3 | 2018 |